Circulating Wnt Signaling Inhibitors and Osteoprotegerin in Women with Newly Diagnosed Overt Thyroid Dysfunction
Metabolites · 30.04.2026 · 16 (5) · 308
DOI: 10.3390/metabo16050308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 30.04.2026. Verfasst von Mariya Zhivkova Miteva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolic Diseases, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Thyroid hormones influence bone metabolism, and autoimmune thyroid diseases may further impact skeletal homeostasis. Wnt signaling inhibitors, including Dickkopf-1 (DKK-1) and sclerostin (SOST), as well as osteoprotegerin (OPG), play key roles in regulating bone formation and resorption. This study aimed to evaluate circulating DKK-1, SOST, and OPG in women with newly diagnosed overt thyroid dysfunction.
Methods
This cross-sectional study included 62 women with newly diagnosed, untreated overt thyroid dysfunction (35 hypothyroid and 27 hyperthyroid) and 33 age- and BMI-matched healthy controls. Serum levels of DKK-1, sclerostin, and OPG were measured using ELISA. Thyroid function and autoantibodies were assessed using automated immunoassays. Correlation analysis was performed to evaluate associations between variables.
Results
Serum DKK-1 levels were significantly elevated in both hypothyroid and hyperthyroid women compared with controls (p < 0.001). Sclerostin levels showed a non-significant trend toward higher values. OPG levels were significantly increased in hyperthyroid patients and moderately elevated in hypothyroid patients. Significant positive correlations were observed between OPG and FT3 (r = 0.42, p = 0.001) and FT4 (r = 0.43, p = 0.001). In hypothyroid patients, OPG correlated positively with TgAb (r = 0.46, p = 0.007). A strong positive correlation was found between DKK-1 and SOST (p < 0.001), while DKK-1 was negatively associated with age (p < 0.05).
Conclusions
Overt thyroid dysfunction is associated with significant alterations in circulating Wnt signaling inhibitors and OPG. These findings suggest a potential role of Wnt signaling and immune–bone interactions in thyroid-related changes in bone metabolism.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolic Diseases, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Clinic of Endocrinology and Metabolic Diseases, "St. George" University Hospital, 4000 Plovdiv, Bulgaria.
- Clinic of Endocrinology and Metabolic Diseases, "Kaspela" University Hospital, 4001 Plovdiv, Bulgaria.
- Department of Clinical Laboratory, Faculty of Medicine, "St. George" University Hospital, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Section of Plastic Reconstructive and Aesthetic Surgery and Thermal Trauma, Department of Propedeutics of Surgical Diseases, Faculty of Medicine, "St. George" University Hospital Plovdiv, Medical University of Plovdiv,…
ORCID-Profile: Mariya Zhivkova Miteva, Boyan Ivanov Nonchev
Zitieren
APA
Miteva, M. Z., Orbetzova, M. M., Nonchev, B. I., Davcheva, D. M., & Gigov, K. (2026). Circulating Wnt Signaling Inhibitors and Osteoprotegerin in Women with Newly Diagnosed Overt Thyroid Dysfunction. Metabolites, 16(5), 308. https://doi.org/10.3390/metabo16050308
Vancouver
Miteva MZ, Orbetzova MM, Nonchev BI, Davcheva DM, Gigov K. Circulating Wnt Signaling Inhibitors and Osteoprotegerin in Women with Newly Diagnosed Overt Thyroid Dysfunction. Metabolites. 2026;16(5):308. doi:10.3390/metabo16050308
BibTeX
@article{Miteva2026,
author = {Miteva, Mariya Zhivkova and Orbetzova, Maria Mitkova and Nonchev, Boyan Ivanov and Davcheva, Delyana Miteva and Gigov, Kostadin},
title = {Circulating Wnt Signaling Inhibitors and Osteoprotegerin in Women with Newly Diagnosed Overt Thyroid Dysfunction},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {5},
pages = {308},
doi = {10.3390/metabo16050308}
}
EUVIMED